Novel (E)-1-(4-methyl-2-(alkylamino)thiazol-5-yl)-3-arylprop-2-en-1-ones as potent antimicrobial agents

Bioorganic and Medicinal Chemistry

Volumn 19, Issue 24, 2011, Pages 7349-7356

  Liaras, K ^a   Geronikaki, A ^a   Glamoclija J ^b   Ciric A ^b   Sokovic M ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Antibacterial; Antifungal; Chalcones; Thiazole

Indexed keywords

1 [2 (ETHYLAMINO) 4 METHYLTHIAZOL 5 YL] 3 (2 METHOXYPHENYL)PROP 2 EN 1 ONE; 1 [2 (ETHYLAMINO) 4 METHYLTHIAZOL 5 YL] 3 (3 FLUOROPHENYL)PROP 2 EN 1 ONE; 1 [2 (ETHYLAMINO) 4 METHYLTHIAZOL 5 YL] 3 (4 FLUOROPHENYL)PROP 2 EN 1 ONE; 1 [2 (ETHYLAMINO) 4 METHYLTHIAZOL 5 YL] 3 (4 METHOXYPHENYL)PROP 2 EN 1 ONE; 1 [2 (ETHYLAMINO) 4 METHYLTHIAZOL 5 YL] 3 (4 NITROPHENYL)PROP 2 EN 1 ONE; 1 [2 (ETHYLAMINO) 4 METHYLTHIAZOL 5 YL] 3 (NITROPHENYL)PROP 2 EN 1 ONE; 1 [2 (ETHYLAMINO) 4 METHYLTHIAZOL 5 YL] 3 PHENYLPROP 2 EN 1 ONE; 1 [4 METHYL 2 (ALKYLOAMINO)THIAZOL 5 YL] 3 ARYLPROP 2 EN 1 ONE DERIVATIVE; 1 [4 METHYL 2 (METHYLAMINO)THIAZOL 5 YL] 3 M TOLYLPROP 2 EN 1 ONE; 1 [4 METHYL 2 (PROPYLAMINO)THIAZOL 5 YL] 3 PHENYLPROP 2 EN 1 ONE; 3 (2 CHLOROPHENYL) 1 [2 (ETHYLAMINO) 4 METHYLTHIAZOL 5 YL]PROP 2 EN 1 ONE; 3 (2,3 DICHLOROPHENYL) 1 [4 METHYL 2 (METHYLAMINO)THIAZOL 5 YL]PROP 2 EN 1 ONE; 3 (3 BROMOPHENYL) 1 [2 (ETHYLAMINO) 4 METHYLTHIAZOL 5 YL]PROP 2 EN 1 ONE; 3 (3 BROMOPHENYL) 1 [4 METHYL 2 (METHYLAMINO)THIAZOL 5 YL]PROP 2 EN 1 ONE; 3 (3 CHLOROPHENYL) 1 [2 (ETHYLAMINO) 4 METHYLTHIAZOL 5 YL]PROP 2 EN 1 ONE; 3 (3 FLUOROPHENYL) 1 [4 METHYL 2 (METHYLAMINO)THIAZOL 5 YL]PROP 2 EN 1 ONE; 3 (4 CHLOROPHENYL) 1 [2 (ETHYLAMINO) 4 METHYLTHIAZOL 5 YL]PROP 2 EN 1 ONE; 3 (4 FLUOROPHENYL) 1 [4 METHYL 2 (METHYLAMINO)THIAZOL 5 YL]PROP 2 EN 1 ONE; AMPICILLIN; BIFONAZOLE; CHALCONE DERIVATIVE; KETOCONAZOLE; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS OCHRACEUS; BACILLUS CEREUS; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; IN VITRO STUDY; LISTERIA MONOCYTOGENES; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIUM; PENICILLIUM FUNICULOSUM; PENICILLIUM OCHROCHLORON; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; TRICHODERMA VIRIDE;

ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

FUNGI; NEGIBACTERIA; POSIBACTERIA;

EID: 82255192933     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2011.10.059     Document Type: Article

References (33)

1. F.C. Tenover, and L.C. McDonald Curr. Opin. Infect. Dis. 18 2005 300
2. R.F. Pfeltz, and B.J. Wilkinson Curr. Drug Targets Infect.Disord. 4 2004 273
3. M.C. Roberts Curr. Drug Targets Infect. Disord. 4 2004 207
4. A. Dessen, A.M. Di Guilmi, T. Vernet, and O. Dideberg Curr. Drug Targets Infect. Disord. 1 2001 63
5. H. Muroi, K. Nihei, K. Tsujimoto, and I. Kubo Bioorg. Med. Chem. 12 2004 583
6. M.W. Khan, M.J. Alam, M.A. Rashid, and R. Chowdhury Bioorg. Med. Chem. 13 2005 4796
7. C. Torres-Viera, and L.M. Dembry Curr. Opin. Infect. Dis. 17 2004 541
8. G.M. Anstead, and A.D. Owens Curr. Opin. Infect. Dis. 17 2004 549
9. C.W. Ford, G.E. Zurenko, and M.R. Barbachyn Curr. Drug Targets Infect. Disord. 1 2001 181
10. P. Vicini, A. Geronikaki, A. Kitka, M. Incerti, and F. Zani Bioorg. Med. Chem. 14 2006 3859
11. I. Rahavi, Ch. Kamoutsis, P. Zoumpoulakis, A. Geronikaki, M. Sokovic, J. Clamocilija, and A. Ciric Bioorg. Med. Chem. 16 2008 1150
12. P. Vicini, A. Geronikaki, M. Incerti, F. Zani, J. Dearden, and M. Hewitt Bioorg. Med. Chem. 16 7 2008 3714
13. Argyropoulou, I.; Geronikaki, A.; Vicini, P.; Zani. F. Arkivoc, Part (vi) Commemorative Issue in Honor of Prof. Henk van der Plas on the occasion of his 80th anniversary 2009.
14. Ch. Camoutsis, A. Geronikaki, A. Ciric, M. Soković, P. Zoumpoulakis, and M. Zervou Chem. Pharm. Bull. 58 2010 160
15. O. Kouatli, P. Zoumpoulakis, Ch. Camoutsis, M. Soković, A. Ćirić, J. Glamočlija, and A. Geronikaki Bioorg. Med. Chem. 18 1 2010 426
16. P. Karegoudar, M.S. Karthikeyan, D.J. Prasad, M. Mahalinga, B.S. Holla, and N.S. Kumari Eur. J. Med. Chem. 43 2008 261
17. P.C. Mhaske, S.H. Shelke, R.P. Jadhav, H.N. Raundal, S.V. Patil, A.A. Patil, and V.D. Bobade J. Heterocycl. Chem. 47 6 2010 1415
18. N.B. Patel, and F.M. Shaikh Sci. Pharm. 78 4 2010 753
19. S. Bondock, W. Khalifa, and A.A. Fadda Eur. J. Med. Chem. 42 2007 948
20. P.M. Gurubasavaraja, and Y.S. Agasimundin Acta Pharmaceutica Sciencia 50 2009 197
21. V. Tomar, G. Bhattacharjee, and K.A. Kumar Bioorg. Med. Chem. Lett. 17 2007 5321
22. Z. Nowakowska, B. Kedzia, and G. Schroeder Eur. J. Med. Chem. 43 4 2008 707
23. N.M.M. Hamada, and E.M. Sharshira Molecules 16 2011 2304 2312
24. P.M.G. Swamy, and Y.S. Agasimundin Acta Pharmaceutica Sciencia 50 2008 197
25. K. Liaras, A. Geronikaki, J. Glamočlija, A. Ćirić, and M. Soković Bioorg. Med. Chem. 19 10 2011 3135
26. E.L. Eliel, and S.H. Wilen Stereochemistry of Organic Compounds 1994 Wiley New York pp. 569
27. Hecht, Chemische Berichte 1890, 23, 286.
28. J. Fatimi, J.-F. Lagorce, M.-L. Chabernaud, F. Comby, J. Buxeraud, and C. Raby Farmaco 49 1994 253
29. A. Agarwal, K. Srivastava, S.K. Purib, and M.S. Chauhan Prem Bioorg. Med. Chem. 13 2005 6226
30. C. Booth Fungal Culture Media J.R. Norris, D.W. Ribbons, Methods in Microbiology vol. 4 1971 Academic Press London and New York 49 94
31. H. Hanel, and W. Raether Mycoses 31 1988 148
32. K.D. Daouk, M.S. Dagher, and J.E. Sattout J. Food Protect. 58 1995 1147
33. A. Espinel-Ingroff J. Clin. Microbiol. 39 2001 1360